Eli Lilly Stock Falls. Novo Extends Lead in Weight-Loss Drug Race [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Eli Lilly's weekly prescriptions for Zepbound declined roughly 2% in the latest reported week ended April 17. In comparison, Novo Nordisk's Wegovy injections recorded a 7% increase over the same period, suggesting differing demand momentum across leading obesity treatments. Warning! GuruFocus has detected 2 Warning Sign with LLY. Is LLY fairly valued? Test your thesis with our free DCF calculator. The update also highlighted Eli Lilly's recently introduced oral therapy, which generated 3,707 prescriptions in its first full week of availability, based on IQVIA tracking data. The launch marks the company's entry into the emerging oral obesity drug segment. By contrast, Novo Nordisk's oral version of Wegovy logged about 18,410 prescriptions during its debut week earlier this year. Analysts noted that early prescription data can fluctuate, though the initial gap may influence investor expectations as Eli Lilly works to expand its position in the competitive weight-loss drug marke
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Why Eli Lilly Stock Flopped on Friday [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Why Eli Lilly Stock Flopped on Friday [Yahoo! Finance]Yahoo! Finance
- Eli Lilly: A Heavyweight Battle Isn't Won In Round 1 [Seeking Alpha]Seeking Alpha
- Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims [Yahoo! Finance]Yahoo! Finance
- Eli Lilly Shares Dip Despite Stable Growth in GLP-1 Prescriptions [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- LLY's page on the SEC website